Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.
Cianchi F, Cortesini C, Magnelli L, Fanti E, Papucci L, Schiavone N, Messerini L, Vannacci A, Capaccioli S, Perna F, Lulli M, Fabbroni V, Perigli G, Bechi P, Masini E.
Cianchi F, et al. Among authors: vannacci a.
Mol Cancer Ther. 2006 Nov;5(11):2716-26. doi: 10.1158/1535-7163.MCT-06-0318.
Mol Cancer Ther. 2006.
PMID: 17121918